Circulating S100B and Adiponectin in Children Who Underwent Open Heart Surgery and Cardiopulmonary Bypass

Background. S100B protein, previously proposed as a consolidated marker of brain damage in congenital heart disease (CHD) newborns who underwent cardiac surgery and cardiopulmonary bypass (CPB), has been progressively abandoned due to S100B CNS extra-source such as adipose tissue. The present study investigated CHD newborns, if adipose tissue contributes significantly to S100B serum levels. Methods. We conducted a prospective study in 26 CHD infants, without preexisting neurological disorders, who underwent cardiac surgery and CPB in whom blood samples for S100B and adiponectin (ADN) measurement were drawn at five perioperative time-points. Results. S100B showed a significant increase from hospital admission up to 24 h after procedure reaching its maximum peak (P < 0.01) during CPB and at the end of the surgical procedure. Moreover, ADN showed a flat pattern and no significant differences (P > 0.05) have been found all along perioperative monitoring. ADN/S100B ratio pattern was identical to S100B alone with the higher peak at the end of CPB and remained higher up to 24 h from surgery. Conclusions. The present study provides evidence that, in CHD infants, S100B protein is not affected by an extra-source adipose tissue release as suggested by no changes in circulating ADN concentrations.

[1]  R. Hemi,et al.  Postoperative Adiponectin Levels in Pediatric Patients Undergoing Open Heart Surgery , 2013, BioMed research international.

[2]  R. Donato,et al.  Functions of S100 proteins. , 2012, Current molecular medicine.

[3]  C. Bernardini,et al.  The S100B protein in biological fluids: more than a lifelong biomarker of brain distress , 2012, Journal of neurochemistry.

[4]  J. Bazarian,et al.  Extracranial Sources of S100B Do Not Affect Serum Levels , 2010, PloS one.

[5]  Z. Tobota,et al.  Analysis of 14,843 neonatal congenital heart surgical procedures in the European Association for Cardiothoracic Surgery Congenital Database. , 2010, The Annals of thoracic surgery.

[6]  H. Huttunen,et al.  S100B Interaction With the Receptor for Advanced Glycation End Products (RAGE): A Novel Receptor-Mediated Mechanism for Myocyte Apoptosis Postinfarction , 2010, Circulation research.

[7]  F. Michetti,et al.  Diagnostic Accuracy of S100B Urinary Testing at Birth in Full-Term Asphyxiated Newborns to Predict Neonatal Death , 2009, PloS one.

[8]  H. Tilg,et al.  Inflammatory Mechanisms in the Regulation of Insulin Resistance , 2008, Molecular medicine.

[9]  P. Roth,et al.  Serum S100B Levels in Patients after Cardiac Surgery: Possible Sources of Contamination , 2007, The Thoracic and cardiovascular surgeon.

[10]  F. Michetti,et al.  Urinary S100B Protein Concentrations Are Increased in Intrauterine Growth-Retarded Newborns , 2006, Pediatrics.

[11]  E. Spada,et al.  Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr) , 2006, Journal of endocrinological investigation.

[12]  A. Denault,et al.  Randomized controlled trial of pericardial blood processing with a cell-saving device on neurologic markers in elderly patients undergoing coronary artery bypass graft surgery. , 2006, The Annals of thoracic surgery.

[13]  H. Castro-Faria-Neto,et al.  Circulating inflammatory mediators and organ dysfunction after cardiovascular surgery with cardiopulmonary bypass: a prospective observational study , 2006, Critical care.

[14]  F. Michetti,et al.  S100B Protein in Urine of Preterm Newborns with Ominous Outcome , 2005, Pediatric Research.

[15]  D. Gazzolo,et al.  Acute Hypoxia Increases S100β Protein in Association with Blood Flow Redistribution away from Peripheral Circulations in Fetal Sheep , 2005, Pediatric Research.

[16]  C. Alling,et al.  Controversial significance of early S100B levels after cardiac surgery , 2004, BMC neurology.

[17]  F. Michetti,et al.  Amniotic fluid S100B protein in mid-gestation and intrauterine fetal death , 2004, The Lancet.

[18]  F. Michetti,et al.  Increased S100B in cerebrospinal fluid of infants with bacterial meningitis: relationship to brain damage and routine cerebrospinal fluid findings. , 2004, Clinical chemistry.

[19]  M. Wiesmann,et al.  Cerebral and extracerebral release of protein S100B in cardiac surgical patients , 2004, Anaesthesia.

[20]  C. Heizmann.  Ca2+-Binding S100 Proteins in the Central Nervous System , 1999, Neurochemical Research.

[21]  F. Michetti,et al.  Phentolamine administration increases blood S100B protein levels in pediatric open‐heart surgery patients , 2003, Acta paediatrica.

[22]  K. Engström,et al.  The inflammatory response to recycled pericardial suction blood and the influence of cell-saving , 2003, Scandinavian cardiovascular journal : SCJ.

[23]  J. Diephuis,et al.  The effect of zero-balanced ultrafiltration during cardiopulmonary bypass on S100b release and cognitive function , 2003, Perfusion.

[24]  H. Jönsson.  S100B and cardiac surgery: possibilities and limitations. , 2003, Restorative neurology and neuroscience.

[25]  M. Cavaglià,et al.  A Glial-Derived Protein, S100B, in Neonates and Infants with Congenital Heart Disease: Evidence for Preexisting Neurologic Injury , 2002, Anesthesia and analgesia.

[26]  F. Michetti,et al.  Circulating S100β Protein Is Increased in Intrauterine Growth-Retarded Fetuses , 2002, Pediatric Research.

[27]  J. Vaage,et al.  Biochemical markers of neurologic injury in cardiac surgery: the rise and fall of S100beta. , 2001, The Journal of thoracic and cardiovascular surgery.

[28]  K. Haglid,et al.  Elevated S100 blood level as an early indicator of intraventricular hemorrhage in preterm infants Correlation with cerebral Doppler velocimetry , 1999, Journal of the Neurological Sciences.

[29]  F. Michetti,et al.  S100 blood concentrations in children subjected to cardiopulmonary by-pass. , 1998, Clinical chemistry.

[30]  C. Heizmann,et al.  The S100 family of EF-hand calcium-binding proteins: functions and pathology. , 1996, Trends in biochemical sciences.

[31]  C. Alling,et al.  Serum S100 protein: a potential marker for cerebral events during cardiopulmonary bypass. , 1996, The Annals of thoracic surgery.

[32]  S. Fulle,et al.  The S-100: A protein family in search of a function , 1995, Progress in Neurobiology.

[33]  Gregory L. Holmes,et al.  Developmental and Neurologic Status of Children after Heart Surgery with Hypothermic Circulatory Arrest or Low-Flow Cardiopulmonary Bypass , 1995 .

[34]  Kanefusa Kato,et al.  Differential distribution of immunoreactive S100-alpha and S100-beta proteins in normal nonnervous human tissues. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[35]  D. Marshak,et al.  Characterization of Human Brain S100 Protein Fraction: Amino Acid Sequence of S100β , 1985, Journal of neurochemistry.

[36]  C. Amiel‐Tison.  Neurological evaluation of the maturity of newborn infants. , 1968, Archives of disease in childhood.

[37]  B. Moore.  A soluble protein characteristic of the nervous system. , 1965, Biochemical and biophysical research communications.